The Nomination Committee’s proposal to the Annual General Meeting 2017
STOCKHOLM, April 6th, 2017. Moberg Pharma AB (OMX: MOB) announces that the company’s Nomination Committee has decided to present the following proposal to the Annual General Meeting 2017.The Nomination CommitteeThe Nomination Committee, consisting of the Chairman Gillis Cullin representing Östersjöstiftelsen and the members Helen Fasth Gillstedt representing Handelsbanken Fonder, Anders Rodebjer representing Wolco Invest and Thomas Eklund, Chairman of the Board of Directors in the Company. Chairman of the Annual General MeetingThe Nomination Committee proposes that Thomas Eklund is